Recent Patents on Anti-Cancer Drug Discovery


Become EABM
Become Reviewer

Most Accessed Articles

Patent Analysis as a Tool for Research Planning: Study on Natural Based Therapeutics Against Cancer Stem Cells promotion: free to download

Volume: 10   Issue: 1
Pp: 72-86
Richa Arya, Smita Bhutkar, Sivakami Dhulap and R. R. Hirwani
DOI: 10.2174/1574892809666140819153102

Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins open access plus

Volume: 13   Issue: 2
Pp: 184-200
Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*
DOI: 10.2174/1574892812666171129141211

Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents

Volume: 14   Issue: 2
Pp: 113-132
Elmira Ekinci, Sagar Rohondia, Raheel Khan and Qingping P. Dou*
DOI: 10.2174/1574892814666190514104035

MDM2-p53 Interaction Inhibitors: The Current State-of-Art and Updated Patent Review (2010-Present)

Volume: 14   Issue: 4
Pp: 324-369
Rafał Rusiecki, Jakub Witkowski* and Jaszczewska-Adamczak Joanna
DOI: 10.2174/1574892814666191022163540

PARP Inhibitors in Ovarian Cancer

Volume: 13   Issue: 4
Pp: 392-410
Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*
DOI: 10.2174/1574892813666180305165256

PARP Inhibitors in Epithelial Ovarian Cancer open access plus

Volume: 13   Issue: 2
Pp: 145-158
Kristin N. Taylor and Ramez N. Eskander*
DOI: 10.2174/1574892813666171204094822

Chimeric Antigen Receptor T Cell Immunotherapy for Tumor: A Review of Patent Literatures open access plus

Volume: 14   Issue: 1
Pp: 60-69
Manxue Fu and Liling Tang*
DOI: 10.2174/1574892814666190111120908

HSP90 Inhibitors: Current Development and Potential in Cancer Therapy promotion: free to download

Volume: 9   Issue: 1
Pp: 1-20
Katerina Sidera and Evangelia Patsavoudi
DOI: 10.2174/15748928113089990031